Luciana Costa

Dr. Luciana Costa

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LCLucio Ayres Caldas
Lucio Ayres Caldas
FCFABIANA AVILA CARNEIRO
FABIANA AVILA CARNEIRO
LHLuiza Mendonça Higa
Luiza Mendonça Higa
FMFábio Luiz Monteiro
Fábio Luiz Monteiro
GSGustavo Peixoto da Silva
Gustavo Peixoto da Silva
WSWanderley de Souza
Wanderley de Souza
SARS-CoV-2 is the cause of the ongoing COVID-19 pandemic. Here, we investigated the interaction of this new coronavirus with Vero cells using high resolution scanning electron microscopy. Surface morphology, the interior of infected cells and the distribution of viral particles in both environments were observed 2 and 48 h after infection. We showed areas of viral processing, details of vacuole contents, and viral interactions with the cell surface. Intercellular connections were also approached, and viral particles were adhered to these extensions suggesting direct cell-to-cell transmission of SARS-CoV-2.

12 July 2021 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
ACAurore Claude-Taupin
Aurore Claude-Taupin
JJJingyue Jia
Jingyue Jia
ZBZambarlal Bhujabal
Zambarlal Bhujabal
MGMeriem Garfa-Traoré
Meriem Garfa-Traoré
SKSuresh Kumar
Suresh Kumar
VDVojo Deretic
Vojo Deretic

26 June 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
MCMarcela S. Cunha
Marcela S. Cunha
PCPedro A. G. Costa
Pedro A. G. Costa
ICIsadora Alonso Correa
Isadora Alonso Correa
MSMarcos Romário Matos De Souza
Marcos Romário Matos De Souza
PCPedro Teles Calil
Pedro Teles Calil
LCLuciana Costa
Luciana Costa
Chikungunya virus (CHIKV) is an arthropod-borne virus (arbovirus) of epidemic concern, transmitted by Aedes ssp. mosquitoes, and is the etiologic agent of a febrile and incapacitating arthritogenic illness responsible for millions of human cases worldwide. After major outbreaks starting in 2004, CHIKV spread to subtropical areas and western hemisphere coming from sub-Saharan Africa, South East Asia, and the Indian subcontinent. Even though CHIKV disease is self-limiting and non-lethal, more than 30% of the infected individuals will develop chronic disease with persistent severe joint pain, tenosynovitis, and incapacitating polyarthralgia that can last for months to years, negatively impacting an individual’s quality of life and socioeconomic productivity. The lack of specific drugs or licensed vaccines to treat or prevent CHIKV disease associated with the global presence of the mosquito vector in tropical and temperate areas, representing a possibility for CHIKV to continually spread to different territories, make this virus an agent of public health burden. In South America, where Dengue virus is endemic and Zika virus was recently introduced, the impact of the expansion of CHIKV infections, and co-infection with other arboviruses, still needs to be estimated. In Brazil, the recent spread of the East/Central/South Africa (ECSA) and Asian genotypes of CHIKV was accompanied by a high morbidity rate and acute cases of abnormal disease presentation and severe neuropathies, which is an atypical outcome for this infection. In this review, we will discuss what is currently known about CHIKV epidemics, clinical manifestations of the human disease, the basic concepts and recent findings in the mechanisms underlying virus-host interaction, and CHIKV-induced chronic disease for both in vitro and in vivo models of infection. We aim to stimulate scientific debate on how the characterization of replication, host-cell interactions, and the pathogenic potential of the new epidemic viral strains can contribute as potential developments in the virology field and shed light on strategies for disease control.

26 December 2020 in medRxiv
Verified
Preprint
Open access
PDF file
CVCarolina M Voloch
Carolina M Voloch
RJRonaldo da Silva F Jr
Ronaldo da Silva F Jr
LALuiz G P de Almeida
Luiz G P de Almeida
CCCynthia Chester Cardoso
Cynthia Chester Cardoso
OBOTAVIO JOSE BERNARDES BRUSTOLINI
OTAVIO JOSE BERNARDES BRUSTOLINI
LWLncc- Workgroup
Lncc- Workgroup
In this study, we report the sequencing of 180 new viral genomes obtained from different municipalities of the state of Rio de Janeiro from April to December 2020. We identified a novel lineage of SARS-CoV-2, originated from B.1.1.28, distinguished by five single-nucleotide variants (SNVs): C100U, C28253U, G28628U, G28975U, and C29754U. The SNV G23012A (E484K), in the receptor-binding domain of Spike protein, was widely spread across the samples. This mutation was previously associated with escape from neutralizing antibodies against SARS-CoV-2. This novel lineage emerged in late July being first detected by us in late October and still mainly restricted to the capital of the state. However, as observed for other strains it can be rapidly spread in the state. The significant increase in the frequency of this lineage raises concerns about public health management and continuous need for genomic surveillance during the second wave of infections. Article Summary Line We identified a novel circulating lineage of SARS-CoV-2 in the state of Rio de Janeiro Brazil originated from B.1.1.28 lineage.

1 January 1999 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
ATAmilcar Tanuri
Amilcar Tanuri
PSPriscilla Swanson
Priscilla Swanson
SDSushil Devare
Sushil Devare
OBOscar J. Berro
Oscar J. Berro
ASAna Savedra
Ana Savedra
MRMark Rayfield
Mark Rayfield
The prevalence of HIV infection in Brazil is one of the highest in the world. In addition, transfusion-transmitted HIV accounts for 2.3% of all AIDS cases in Brazil. The objective of this study was to evaluate genetic diversity and distribution of HIV-1 strains circulating in the blood-donor population. We characterized 43 seropositive blood units collected from volunteer blood donors residing throughout Rio de Janeiro, Brazil. Viral RNA was extracted from plasma, reverse transcribed, and amplified by nested polymerase chain reaction (PCR) using HIV group M degenerate primers. Genetic heterogeneity was evaluated by direct automated cycle sequencing of the following gene fragments: gag p24 (399 bp), env C2V3 (345 bp), and env gp41 (369 bp). Phylogenetic analysis reflected the complexity of the Brazilian HIV epidemic: the majority of specimens, 33 of 43 (76.7%) were subtype B, and 6 of 43 (14%) were subtype F. The remaining 4 samples (9.3%) involved potential mosaic viruses of subtypes B and F or B and D. This survey is the first to document HIV-1 genetic variation in the Brazilian blood-donor population.

9 June 2006 in Retrovirology
Verified
Journal Article
Open access
LCLuciana Costa
Luciana Costa
NCNan Chen
Nan Chen
ALAdriana Lopes
Adriana Lopes
RARenato Aguiar
Renato Aguiar
ATAmilcar Tanuri
Amilcar Tanuri
Boris PeterlinBoris Peterlin
Boris Peterlin
Background: Nef is an accessory protein of primate lentiviruses, HIV-1, HIV-2 and SIV. Besides removing CD4 and MHC class I from the surface and activating cellular signaling cascades, Nef also binds GagPol during late stages of the viral replicative cycle. In this report, we investigated further the ability of Nef to facilitate the replication of HIV-1. Results: To this end, first the release of new viral particles was much lower in the absence of Nef in a T cell line. Since the same results were obtained in the absence of the viral envelope using pseudo-typed viruses, this phenomenon was independent of CD4 and enhanced infectivity. Next, we found that Nef not only possesses a consensus motif for but also binds AIP1 in vitro and in vivo. AIP1 is the critical intermediate in the formation of multivesicular bodies (MVBs), which play an important role in the budding and release of viruses from infected cells. Indeed, Nef proliferated MVBs in cells, but only when its AIP1-binding site was intact. Finally, these functions of Nef were reproduced in primary macrophages, where the wild type but not mutant Nef proteins led to increased release of new viral particles from infected cells. Conclusion: We conclude that by binding GagPol and AIP1, Nef not only proliferates MVBs but also contributes to the egress of viral particles from infected cells.